摘要
乳腺导管原位癌(ductal carcinoma in situ,DCIS)属于非浸润性乳腺癌,病理形态学表现为乳腺导管上皮细胞癌变且局限于导管的基膜内,未侵犯间质,临床发病率约占乳腺癌的10%左右。
出处
《中华乳腺病杂志(电子版)》
CAS
CSCD
2016年第4期249-251,共3页
Chinese Journal of Breast Disease(Electronic Edition)
基金
深圳市科技创新委员会项目(编号:JCYJ2013031200503931)
参考文献14
-
1邵志敏,沈镇宙,徐兵河,主编.乳腺肿瘤学[M].上海:复旦大学出版社,2013: 24-25.
-
2Cuzick J, Sestak I, Pindcr SE, et al. Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial [ J ]. Lancet Oncol,2011,12(1):21-29.
-
3朱思吉,沈坤炜.乳腺导管内癌的外科治疗进展[J].中华医学杂志,2014,94(48):3865-3867. 被引量:3
-
4Zavagno G, Carcoforo P, Marconato R, et al. Role of axillary sentinel lymph node biopsy in patients pure ductal carcinoma in situ of the breast[J]. BMC Cancer,2005,5:28.
-
5Ko BS, Lim WS, Kim HI, et al. Risk factor for axillary lymph node metastases in microinvasive breast cancer[J]. Ann Surg Oncol, 2012, 19(1) :212-216.
-
6Silver SA, Tavassoli FA. Mammary ductal carcinoma in situ with microinvasion. [J]. Cancer, 1998, 82(12) :2382-3290.
-
7Smigal C, Jemal A, Ward E, et al. Trends in breast cancer by race and ethnicity: update 2006[J]. CA Cancer J Clin, 2006, 56(3) :168- 183.
-
8Castellana B, Escuin D, Peir6 G, ct al. ASPN and GJB2 are implicated in the mechanisms of invasion of ductal breast carcinomas [J]. JCancer, 2012, 3:175-183.
-
9Volinia S, Galasso M, Sana ME, et al. Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA [J]. Proc Natl Acad Sci U S A, 2012, 109(8) :3024-3029.
-
10Hughes LL, Wang M, Page DL, et al. Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group[J]..I Clin Oncol,2009,27 (32) : 5319-5324.
二级参考文献38
-
1张荣新,范江,王圣应,王磊,王朝夫,李同度.Survivin在乳腺癌组织中的表达及其临床意义[J].肿瘤防治杂志,2005,12(19):1476-1479. 被引量:4
-
2Harris JR, Lippman ME, Veronesi U, et al. Breast cancer(2)[J].N EnglJ Med, 1992, 327(6): 390-398.
-
3Burstein HJ, Polyak K, WongJS, et al. Ductal carcinoma in situ of the breast[J].N EnglJ Med, 2004, 350(14): 1430-1441.
-
4Levine M. Cfinical practice guidelines for the care and treatment of breast cancer: adjuvant systemic therapy for node-negative breast cancer (summary of the 2001 update)[J]. CMAJ, 2001, 164(2): 213.
-
5Solin LJ, Fourquet A, Vicini FA, et al. Salvage treatment for local re- currence after breast-conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast[J]. Cancer, 2001, 91(6): 1090-1097.
-
6The management of ductal carcinoma in situ(DCIS). The SteeringCommittee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Canadian Association of Radiation Oncologists[J]. CMAJ, 1998, 158 Suppl 3: $27-34.
-
7HoughtonJ, George WD, GuzickJ, et al. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled triM[J].Lancet, 2003, 362(9378): 95-109.
-
8Cuzick J, Sestak I, Pinder SE, et al. Effect of tamoxifen and radio- therapy in women with locally excised ductal carcinoma in situ: long-term results from the LrK/ANZ DCIS trial[J]. Lancet Oncol, 2011, 12(1): 21-29.
-
9Fisher B, DignamJ, Wolmark N, et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: mdings from National Surgical Adjuvant Breast and Bowel Project B-17[J].J Clin Oncol, 1998, 16(2): 441-452.
-
10Bijker N, Meijnen P, Peterse JL, et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-sire: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase Ill trial 10853-a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group [J]. ] Clin Oncol, 2006, 24(21): 3381-3387.
共引文献64
-
1郑育强,李帅,宋磊,李晨,李小雷,李维清.乳腺导管原位癌术后复发转移一例[J].新疆医学,2023,53(10):1283-1284.
-
2史东波,周官保,柯孔亮.多中心性乳腺导管内癌的诊治分析[J].医学研究杂志,2012,41(4):148-150.
-
3张磊,郑丽坤,姜海平.瘦素对乳腺癌细胞Survivin表达影响的观察[J].中华肿瘤防治杂志,2013,20(7):502-504. 被引量:2
-
4牛献勇.乳腺导管内隆起性病变的临床分析[J].中国医药,2014,9(2):247-249. 被引量:3
-
5董洁.滋水清肝饮合耳穴贴压治疗他莫昔芬性绝经46例[J].中国中医药现代远程教育,2014,12(7):38-39.
-
6王永高,地力木拉提.艾斯木吐拉,栾梅香,阿迪力江.买买提明.雌二醇对唑来膦酸预防乳腺癌骨转移疗效的影响[J].中国普外基础与临床杂志,2014,21(5):572-576.
-
7许锐,陈亚丽,胡学军,刘晓雁.广州市低保低收入妇女乳腺普查结果分析[J].山西医药杂志,2014,43(10):1120-1121.
-
8阿迪力江.买买提明,郭瑞,地力木拉提.艾斯木吐拉,栾梅香.唑来膦酸预防乳腺癌骨转移的疗效研究[J].中国普外基础与临床杂志,2014,21(6):698-701.
-
9孙莹,于晶,魏军民,樊聪,王秀问,高鹏,江立玉,马婷婷.35岁以下女性乳腺癌患者的临床病理特征[J].山东大学学报(医学版),2014,52(7):71-74. 被引量:10
-
10刘福东.乳腺导管原位癌保乳治疗的临床效果及安全性研究[J].中国实用乡村医生杂志,2014,0(17):59-60. 被引量:1
同被引文献17
-
1邵志敏,沈镇宙,徐兵河,主编.乳腺肿瘤学[M].上海:复旦大学出版社,2013: 24-25.
-
2Cuzick J, Sestak I, Pindcr SE, et al. Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial [ J ]. Lancet Oncol,2011,12(1):21-29.
-
3Zavagno G, Carcoforo P, Marconato R, et al. Role of axillary sentinel lymph node biopsy in patients pure ductal carcinoma in situ of the breast[J]. BMC Cancer,2005,5:28.
-
4Ko BS, Lim WS, Kim HI, et al. Risk factor for axillary lymph node metastases in microinvasive breast cancer[J]. Ann Surg Oncol, 2012, 19(1) :212-216.
-
5Silver SA, Tavassoli FA. Mammary ductal carcinoma in situ with microinvasion. [J]. Cancer, 1998, 82(12) :2382-3290.
-
6Smigal C, Jemal A, Ward E, et al. Trends in breast cancer by race and ethnicity: update 2006[J]. CA Cancer J Clin, 2006, 56(3) :168- 183.
-
7Castellana B, Escuin D, Peir6 G, ct al. ASPN and GJB2 are implicated in the mechanisms of invasion of ductal breast carcinomas [J]. JCancer, 2012, 3:175-183.
-
8Volinia S, Galasso M, Sana ME, et al. Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA [J]. Proc Natl Acad Sci U S A, 2012, 109(8) :3024-3029.
-
9Hughes LL, Wang M, Page DL, et al. Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group[J]..I Clin Oncol,2009,27 (32) : 5319-5324.
-
10刘现军,金东岭,席丰,时志民.乳腺导管内癌中Ezrin和Survivin表达及临床病理意义[J].中国实验诊断学,2011,15(1):69-71. 被引量:6
引证文献2
-
1郑育强,李帅,宋磊,李晨,李小雷,李维清.乳腺导管原位癌术后复发转移一例[J].新疆医学,2023,53(10):1283-1284.
-
2崔军威,杨满,李朋,韦伟.乳腺导管原位癌术后全身多脏器转移一例[J].中华乳腺病杂志(电子版),2016,10(4):249-251. 被引量:2
二级引证文献2
-
1郑育强,李帅,宋磊,李晨,李小雷,李维清.乳腺导管原位癌术后复发转移一例[J].新疆医学,2023,53(10):1283-1284.
-
2崔军威,杨满,李朋,韦伟.乳腺导管原位癌术后全身多脏器转移一例[J].中华乳腺病杂志(电子版),2016,10(4):249-251. 被引量:2
-
1周智群,黄鹏,林广荣,刘汉武.结肠癌根治术后复发转移的特点分析[J].中国医药指南,2013,11(2):458-459. 被引量:2
-
2阿迪力江.买买提明,郭瑞,地力木拉提.艾斯木吐拉,栾梅香.唑来膦酸预防乳腺癌骨转移的疗效研究[J].中国普外基础与临床杂志,2014,21(6):698-701.
-
3解亦斌,赵平,王成锋,单毅,赵东兵,刘骞,白晓枫.胰腺导管腺癌根治性切除术后复发转移及预后影响因素分析[J].中华肿瘤杂志,2008,30(9):686-689. 被引量:1
-
4方淑珍.雌激素受体及C-erbB-2的表达与乳腺癌术后应用放疗的关系[J].中国医师进修杂志(外科版),2007,30(6):42-43.
-
5黄兰柱,唐恩溢,丁洁,邓润智.颌面部肉瘤临床疗效分析[J].口腔医学研究,2012,28(7):714-716. 被引量:3
-
6曾国群.甲状腺髓样癌多脏器转移1例[J].内科,2010,5(5):539-540. 被引量:1
-
7陈世民.恶性肿瘤血型抗原表达改变及其发生机制[J].国外医学(输血及血液学分册),1997,20(5):279-282. 被引量:2
-
8李坚,周凯,王俊.CIP2A与c-Myc在乳腺癌中的表达及临床意义[J].江西医药,2016,51(12):1330-1333. 被引量:9
-
9刘勇,蒋莉,路名芝,涂琦.采用组织芯片技术分析乳腺癌中PTEN对HIF-1α表达的影响[J].江西医药,2007,42(4):297-300.
-
10周珩,吴云飞,冯俊.表皮生长因子和血管内皮生长因子在乳腺癌中的表达及临床意义[J].山西医药杂志(下半月),2012,41(12):1242-1243. 被引量:3